Efficacy of Ivermectin against Strongyloides Stercoralis in Humans.
スポンサーリンク
概要
- 論文の詳細を見る
Okinawa Prefecture is an endemic area of Strongyloides stercoralis infection. Since treatment of this infection remains unsatisfactory, we evaluated the efficacy of ivermectin. Twenty-three patients were treated with a single oral dose of ivermectin (mean±SD, 105.5±20.8 mcg/kg of body weight), followed by a second dose two weeks later. The rate of cure was 85.7% at 2 weeks after the first treatment, and 90.5% at 2 weeks after the second treatment. Side effects occurred in 2 patients (8.7%), but they were mild and transient. The results indicate that ivermectin might be useful and relatively safe for the therapy of Strongyloides stercoralis infection as an alternative to thiabendazole or mebendazole.(Internal Medicine 31 : 310-312, 1992)
- 社団法人 日本内科学会の論文
著者
-
Kinjo Fukunori
The First Department Of Internal Medicine Faculty Of Medicine University Of Ryukyus
-
Saito Atsushi
The First Department Of Internal Medicine Faculty Of Medicine University Of Ryukyus
-
KINJO Nagisa
the First Department of Internal Medicine, Faculty of Medicine, University of the Ryukyus
-
SHIKIYA Koushin
the First Department of Internal Medicine, Faculty of Medicine, University of the Ryukyus
-
UEHARA Takeshi
the First Department of Internal Medicine, Faculty of Medicine, University of the Ryukyus
-
UECHI Hiroyuki
the First Department of Internal Medicine, Faculty of Medicine, University of the Ryukyus
-
OHSHIRO Junichi
the First Department of Internal Medicine, Faculty of Medicine, University of the Ryukyus
-
ARAKAKI Tamiki
the First Department of Internal Medicine, Faculty of Medicine, University of the Ryukyus
-
IJU Mamoru
the First Department of Internal Medicine, Faculty of Medicine, University of the Ryukyus
-
KOBARI Kazumine
Ohama First Hospital
関連論文
- Comparison of anthelmintic effects of two doses of ivermectin on intestinal strongyloidiasis in patients negative or positive for anti-HTLV-1 antibody
- Efficacy of ivermectin for chronic strongyloidiasis : two single doses given 2 weeks apart
- Strongyloidiasis - Progress in Diagnosis and Treatment
- Concurrent Infection with Legionella pneumophila and Pneumocystis carinii in a Patient with Adult T cell Leukemia
- In Vitro and In Vivo Evaluation of the Antimicrobial Acitivity of Azithromycin against Legionella Species
- Symposium on Molecular Pathogenesis of Respiratory Diseases and Its Clinical Implication, Respiratory Tract Infection
- Different Susceptibility of Three Clinically Isolated Strains of Cryptococcus neoformans to the Fungicidal Effects of Reactive Nitrogen and Oxygen Intermediates:Possible Relationships with Virulence
- Successful Long-term Treatment with Cyclosporin A in Protein Losing Gastroenteropathy
- A Patient with Primary Biliary Cirrhosis Complicated with Slowly Progressive Insulin-dependent Diabetes Mellitus
- NK Cells Eliminate Cryptococcus neoformans by Potentiating the Fungicidal Activity of Macrophages Rather than by Directly Killing Them upon Stimulation with IL-12 and IL-18
- Circulating Soluble CD4 Directly Prevents Host Resistance and Delayed-Type Hypersensitivity Response to Cryptococcus neoformans in Mice
- Herpes Simplex Virus Bronchopneumonia in a Non-immunocompromized Individual
- Improvement of Filter Properties Using Sapphire and Nickel Rod Trimmers( Superconducting High-frequency Devices)
- Community-acquired Chlamydia pneumoniae Pneumonia in Japan : A Prospective Multicenter Community-acquired Pneumonia Study
- Legionella pneumophila Pneumonia Successfully Treated with Intravenous Ciprofloxacin
- Legionella Pneumonia : Present Status in Japan
- Activation of Unusual Mac-1^+CD4^-CD8^- T Cells Bearing αβ Antigen Receptor in Murine Lungs during Infection with Mycobacterium bovis BCG: Regulation by Interferon-γ
- Transthoracic Needle Aspiration: A Useful Technique to Detect Causative Organisms of Pneumonia
- Efficacy of Ivermectin against Strongyloides Stercoralis in Humans.
- Hereditary Angioedema: A Case with Ascites Yet No Symptoms in the Family.